111 Price to Free Cash Flow Ratio 2018-2024 | YI

Historical price to free cash flow ratio values for 111 (YI) since 2018. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
111 Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-11-21 0.61 19.65
2024-06-30 1.07 $0.03 34.13
2024-03-31 1.16 $-0.37 0.00
2023-12-31 1.55 $-0.76 0.00
2023-09-30 2.60 $-0.35 0.00
2023-06-30 2.46 $-0.39 0.00
2023-03-31 2.65 $-0.18 0.00
2022-12-31 3.02 $-0.09 0.00
2022-09-30 2.68 $-0.87 0.00
2022-06-30 2.06 $-1.10 0.00
2022-03-31 2.66 $-1.07 0.00
2021-12-31 3.50 $-1.42 0.00
2021-09-30 6.17 $-1.04 0.00
2021-06-30 9.09 $-0.01 0.00
2021-03-31 13.80 $-0.47 0.00
2020-12-31 6.95 $-0.16 0.00
2020-09-30 6.20 $0.07 88.32
2019-09-30 4.87 $-0.35 0.00
2019-06-30 5.56 $-0.83 0.00
2019-03-31 6.49 $-0.45 0.00
2018-09-30 13.52 $-0.54 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.052B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.263B 0.00
Inspire Medical Systems (INSP) United States $5.580B 174.01
Hims & Hers Health (HIMS) United States $5.276B 134.17
Enovis (ENOV) United States $2.580B 17.49
Privia Health (PRVA) United States $2.530B 210.80
IRhythm Technologies (IRTC) United States $2.313B 0.00
Azenta (AZTA) United States $2.227B 111.05
Omnicell (OMCL) United States $2.043B 66.83
Clover Health Investments (CLOV) United States $1.684B 0.00
10x Genomics (TXG) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.484B 0.00
Phreesia (PHR) United States $1.098B 0.00
Butterfly Network (BFLY) United States $0.701B 0.00
Standard BioTools (LAB) United States $0.603B 0.00
Talkspace (TALK) United States $0.559B 0.00
Fulgent Genetics (FLGT) United States $0.518B 0.00
Definitive Healthcare (DH) United States $0.491B 85.00
Health Catalyst (HCAT) United States $0.466B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
TruBridge (TBRG) United States $0.239B 69.61
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.075B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Zepp Health (ZEPP) China $0.038B 0.00
Movano (MOVE) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.010B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00